Serum markers thrombophilia in pregnant women with Systemic Lupus Erythematosus

Abstract Objectives: to determine the frequency of serum markers for hereditary and acquired thrombophilia and their association with pregnancy in women with Systemic Lupus Erythematosus (SLE). Methods: a case-control study was conducted among 25 pregnant women with SLE (study group) and 32 pregna...

Full description

Bibliographic Details
Main Authors: Vanessa Marcon de Oliveira, Ernesto Antonio Figueiró-Filho, Cristiane Munaretto Ferreira, Erica Freire de Vasconcelos Pereira
Format: Article
Language:English
Published: Instituto Materno Infantil de Pernambuco
Series:Revista Brasileira de Saúde Materno Infantil
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1519-38292017000400833&lng=en&tlng=en
_version_ 1818433934680129536
author Vanessa Marcon de Oliveira
Ernesto Antonio Figueiró-Filho
Cristiane Munaretto Ferreira
Erica Freire de Vasconcelos Pereira
author_facet Vanessa Marcon de Oliveira
Ernesto Antonio Figueiró-Filho
Cristiane Munaretto Ferreira
Erica Freire de Vasconcelos Pereira
author_sort Vanessa Marcon de Oliveira
collection DOAJ
description Abstract Objectives: to determine the frequency of serum markers for hereditary and acquired thrombophilia and their association with pregnancy in women with Systemic Lupus Erythematosus (SLE). Methods: a case-control study was conducted among 25 pregnant women with SLE (study group) and 32 pregnant women without known disease and with at least one previous pregnancy (control group). The presence of antiphospholipid antibodies and hereditary thrombophilia were examined in both groups. We used the y2 Test with Yates correction or Fisher's Exact Test to verify the associations and calculate the relative risk. Results: thrombophilia was present in 72.0% of pregnant women with SLE and in 6.0% of patients in the control group. A significant association was found between the presence of SLE and serum markers for hereditary thrombophilia / antiphospholipid antibodies (p<0.05). The relative risks for antiphospholipid antibodies were 13.20 (ICR95%= 1.81 - 96.46) in pregnant women with SLE, 7.26 (CI95%= 1.77 - 29.86) for the presence of serum markers of hereditary thrombophilia and 7.92 (CI95%= 2.62 - 3.94) for the presence of hereditary thrombophilia and/or antiphospholipid antibodies. Conclusions: the identification of markers for hereditary and/or acquired thrombophilia in pregnant women with lupus may be clinically useful to determine which patients have a higher risk of obstetric complications.
first_indexed 2024-12-14T16:28:59Z
format Article
id doaj.art-3296887417874660bf05b6fe27f8fce6
institution Directory Open Access Journal
issn 1806-9304
language English
last_indexed 2024-12-14T16:28:59Z
publisher Instituto Materno Infantil de Pernambuco
record_format Article
series Revista Brasileira de Saúde Materno Infantil
spelling doaj.art-3296887417874660bf05b6fe27f8fce62022-12-21T22:54:37ZengInstituto Materno Infantil de PernambucoRevista Brasileira de Saúde Materno Infantil1806-930417483384210.1590/1806-93042017000400012S1519-38292017000400833Serum markers thrombophilia in pregnant women with Systemic Lupus ErythematosusVanessa Marcon de OliveiraErnesto Antonio Figueiró-FilhoCristiane Munaretto FerreiraErica Freire de Vasconcelos PereiraAbstract Objectives: to determine the frequency of serum markers for hereditary and acquired thrombophilia and their association with pregnancy in women with Systemic Lupus Erythematosus (SLE). Methods: a case-control study was conducted among 25 pregnant women with SLE (study group) and 32 pregnant women without known disease and with at least one previous pregnancy (control group). The presence of antiphospholipid antibodies and hereditary thrombophilia were examined in both groups. We used the y2 Test with Yates correction or Fisher's Exact Test to verify the associations and calculate the relative risk. Results: thrombophilia was present in 72.0% of pregnant women with SLE and in 6.0% of patients in the control group. A significant association was found between the presence of SLE and serum markers for hereditary thrombophilia / antiphospholipid antibodies (p<0.05). The relative risks for antiphospholipid antibodies were 13.20 (ICR95%= 1.81 - 96.46) in pregnant women with SLE, 7.26 (CI95%= 1.77 - 29.86) for the presence of serum markers of hereditary thrombophilia and 7.92 (CI95%= 2.62 - 3.94) for the presence of hereditary thrombophilia and/or antiphospholipid antibodies. Conclusions: the identification of markers for hereditary and/or acquired thrombophilia in pregnant women with lupus may be clinically useful to determine which patients have a higher risk of obstetric complications.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1519-38292017000400833&lng=en&tlng=enSystemic lupus erythematosusThrombophiliaAntiphospholipid syndromePregnancy complicationshematologic
spellingShingle Vanessa Marcon de Oliveira
Ernesto Antonio Figueiró-Filho
Cristiane Munaretto Ferreira
Erica Freire de Vasconcelos Pereira
Serum markers thrombophilia in pregnant women with Systemic Lupus Erythematosus
Revista Brasileira de Saúde Materno Infantil
Systemic lupus erythematosus
Thrombophilia
Antiphospholipid syndrome
Pregnancy complications
hematologic
title Serum markers thrombophilia in pregnant women with Systemic Lupus Erythematosus
title_full Serum markers thrombophilia in pregnant women with Systemic Lupus Erythematosus
title_fullStr Serum markers thrombophilia in pregnant women with Systemic Lupus Erythematosus
title_full_unstemmed Serum markers thrombophilia in pregnant women with Systemic Lupus Erythematosus
title_short Serum markers thrombophilia in pregnant women with Systemic Lupus Erythematosus
title_sort serum markers thrombophilia in pregnant women with systemic lupus erythematosus
topic Systemic lupus erythematosus
Thrombophilia
Antiphospholipid syndrome
Pregnancy complications
hematologic
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1519-38292017000400833&lng=en&tlng=en
work_keys_str_mv AT vanessamarcondeoliveira serummarkersthrombophiliainpregnantwomenwithsystemiclupuserythematosus
AT ernestoantoniofigueirofilho serummarkersthrombophiliainpregnantwomenwithsystemiclupuserythematosus
AT cristianemunarettoferreira serummarkersthrombophiliainpregnantwomenwithsystemiclupuserythematosus
AT ericafreiredevasconcelospereira serummarkersthrombophiliainpregnantwomenwithsystemiclupuserythematosus